These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1513472)

  • 1. Metabolism of glucurolactone to glucarate in Parkinson's disease.
    Koller WC; Rope SD; Huber SJ; Blumenthal DC; Blumenthal HJ
    Neurology; 1992 Sep; 42(9):1807-8. PubMed ID: 1513472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look.
    Tanner CM
    Neurology; 1991 May; 41(5 Suppl 2):89-91; discussion 92. PubMed ID: 2041601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver enzyme abnormalities in Parkinson's disease.
    Tanner CM
    Geriatrics; 1991 Aug; 46 Suppl 1():60-3. PubMed ID: 1894148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific enzymatic assay for D-glucarate in human serum.
    Blumenthal HJ; Lucuta VL; Blumenthal DC
    Anal Biochem; 1990 Mar; 185(2):286-93. PubMed ID: 2187374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.
    Lecamwasam DS; Franklin C; Turner P
    Br J Clin Pharmacol; 1975 Jun; 2(3):257-62. PubMed ID: 1234506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetaminophen metabolism by cytochrome P450 monooxygenases in Parkinson's disease.
    Factor SA; Weiner WJ; Hefti F
    Ann Neurol; 1989 Aug; 26(2):286-8. PubMed ID: 2774516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man.
    Lecamwasam DS
    Br J Clin Pharmacol; 1975 Dec; 2(6):546-8. PubMed ID: 1234021
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease.
    Peeters EA; Bloem BR; Kuiper MA; Vermeij P; de Wolff FA; Wolters EC; Roos RA; Ferrari MD
    Clin Neurol Neurosurg; 1994 Nov; 96(4):296-9. PubMed ID: 7889690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease.
    Riedl AG; Watts PM; Brown CT; Jenner P
    Adv Neurol; 1999; 80():271-86. PubMed ID: 10410732
    [No Abstract]   [Full Text] [Related]  

  • 10. Indirect evidence for hepatic induction in patients with cholesterol gallstones.
    Sandle LN; Worthington HV; Rameh B; Braganza JM
    Biochem Soc Trans; 1997 Aug; 25(3):412S. PubMed ID: 9388642
    [No Abstract]   [Full Text] [Related]  

  • 11. CHANGES IN ENZYME ACTIVITY, RELATED TO D-GLUCARIC ACID SYNTHESIS, WITH AGE, PREGNANCY AND MALIGNANCY.
    MARSH CA; CARR AJ
    Clin Sci; 1965 Apr; 28():209-17. PubMed ID: 14277294
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochrome P450 and Parkinson's disease. Poor parahydroxylation of phenytoin.
    Ferrari MD; Peeters EA; Haan J; Roos RA; Vermey P; de Wolff FA; Buruma OJ
    J Neurol Sci; 1990 May; 96(2-3):153-7. PubMed ID: 2376747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease].
    Yoshino H; Hattori Y; Imai H; Narabayashi H; Chiba K
    Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test.
    Aoyama K; Matsubara K; Okada K; Fukushima S; Shimizu K; Yamaguchi S; Uezono T; Satomi M; Hayase N; Ohta S; Shiono H; Kobayashi S
    J Neural Transm (Vienna); 2000; 107(8-9):985-95. PubMed ID: 11041277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-glucaric-acid excretion as a test for hepatic enzyme induction.
    Aarts EM
    Lancet; 1971 Apr; 1(7704):859. PubMed ID: 4102545
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of lung cancer chemoprevention by D-glucarate.
    Walaszek Z; Hanausek M; Narog M; Raich PC; Slaga TJ
    Chest; 2004 May; 125(5 Suppl):149S-50S. PubMed ID: 15136472
    [No Abstract]   [Full Text] [Related]  

  • 18. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):911-3. PubMed ID: 8057112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of liver regeneration on hepatic cytochrome P450 isozymes and serum sex steroids in the male rat.
    Liddle C; Murray M; Farrell GC
    Gastroenterology; 1989 Mar; 96(3):864-72. PubMed ID: 2914647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the functional reserve of the human liver by urinary D-glucaric acid excretion after vitamin C administration.
    Hanaue H; Kanno K; Mukai M; Kubo H; Tobita K; Nakasaki H; Tajima T; Mitomi T; Endo R
    Tokai J Exp Clin Med; 1993 Jun; 18(1-2):1-4. PubMed ID: 7940601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.